Thanks stokdog!
Goodness me, a number of take aways from that, chock full of info. This will be a rather useful resource, though pending announcements, maybe small cheese.
Just a couple of quick things.
If you are chasing CHF rights outside of China, probably too late, being snaffled.
And the issue of sorting out reimbursement rates in a timely manner with approval/registration, this for the aGVHD solution. In relation to the speed bump Takeda are having at the moment.
Cell Therapy News/Articles, page-193
-
- There are more pages in this discussion • 17,626 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.010(0.91%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $4.794M | 4.399M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14500 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 141676 | 5 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |